Current Research Interests
Dr. Du is a cancer epidemiologist who works with international teams to reduce the global burden of endometrial, colorectal, and pancreatic cancers, particularly in populations who face the poorest outcomes. She studies tumor biology and risk profiles to help inform risk-reducing education, lifestyle changes, or early detection. She leads the Data Coordinating Center and co-chairs the Executive Committee for E2C2 (Epidemiology of Endometrial Cancer Consortium), investigating racial disparities in endometrial cancer mortality. She studies colorectal cancer genomics and risk factors, including in Nigeria through ARGO (African Research Group for Oncology). She leads the MSK Pancreatic Tumor Registry, where she examines the causes of pancreatic cancer and screening and risk evaluation in high-risk individuals. Her work is funded by the NCI, NCATS, David M. Rubenstein Center for Pancreatic Cancer Research, and philanthropic sources.
Committed to education and mentoring, Dr. Du directs MSK’s QSURE (Quantitative Sciences Undergraduate Research Experience) program. She holds a joint appointment as Associate Professor at Weill Cornell Medicine, where she directs the TL1 Predoctoral Training Core and teaches Foundations of Epidemiology in the Clinical and Translational Science Center. She serves on the MSK Research Council and as Associate Editor for Cancer Causes & Control.
View a full listing of Mengmeng (Margaret) Du’s journal articles.
My Projects
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Mengmeng (Margaret) Du discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures
